NCT02680002 - Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant | Biotech Hunter

Enrollment

422

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

May 13, 2016

Study Completion Date

March 31, 2017

Conditions

A/Vietnam/H5N1 Influenza Virus

Interventions

BIOLOGICAL

7.5 mcg H5N1 (stored as monobulk)

BIOLOGICAL

15 mcg H5N1 (stored as monobulk)

BIOLOGICAL

90 mcg H5N1 (stored as monobulk)

BIOLOGICAL

90 mcg H5N1 (stored in vials)

OTHER

MF59

OTHER

MF59 (stored as monobulk)

Trial Locations (6)

Rochester Clinical Research, Inc., Rochester

Radiant Research, Inc., Atlanta

Central Kentucky Researcch Associates, Inc., Lexington

Clinical Research Advantage, Inc./Ridge Family Practice, Council Bluffs

Radiant Research, Inc., Edina

Johnson County Clin-Trials, Inc., Lenexa